| Literature DB >> 35720675 |
Eric Y Ding1, Maira CastañedaAvila2, Khanh-Van Tran1, Jordy Mehawej1, Andreas Filippaios1, Tenes Paul1, Edith Mensah Otabil1, Kamran Noorishirazi1, Dong Han3, Jane S Saczynski4, Bruce Barton2, Kathleen M Mazor1, Ki Chon3, David D McManus1.
Abstract
Background: Smartwatches can be used for atrial fibrillation (AF) detection, but little is known about how older adults at risk for AF perceive their usability.Entities:
Keywords: Acceptability; Atrial fibrillation; Smartwatch; Stroke; Usability
Year: 2022 PMID: 35720675 PMCID: PMC9204791 DOI: 10.1016/j.cvdhj.2022.03.003
Source DB: PubMed Journal: Cardiovasc Digit Health J ISSN: 2666-6936
Figure 1Pulsewatch study structure. Data from participants in the Phase I intervention group of the Pulsewatch trial.
Baseline characteristics of participants
| Demographics (N = 90 participants) | Result |
|---|---|
| Age, mean, y (SD) | 65.1 (9.3) |
| Female | 37 (41%) |
| Race | |
| White | 78 (87%) |
| More than 1 race | 6 (7%) |
| Black | 1 (1%) |
| Asian/Pacific Islander | 1 (1%) |
| Other | 4 (4%) |
| Non-Hispanic ethnicity | 87 (97%) |
| Married/living as married | 61 (69%) |
| Education | |
| Less than high school | 4 (5%) |
| High school degree or equivalent | 38 (43%) |
| College degree | 28 (32%) |
| Postgraduate degree | 18 (20%) |
| Income | |
| <$50,000 | 29 (35%) |
| $50,000–$99,999 | 27 (33%) |
| ≥$100,000 | 27 (33%) |
| Medical history | |
| History of ischemic stroke | 71 (79%) |
| History of TIA | 26 (29%) |
| Congestive heart failure | 6 (7%) |
| Cardiac arrhythmias | 12 (13%) |
| Valvular disease | 9 (10%) |
| Hypertension | 70 (78%) |
| Chronic pulmonary disease | 7 (8%) |
| Diabetes | 25 (28%) |
| Vascular disease | 24 (27%) |
| Renal disease | 4 (4%) |
| Prior major bleed | 5 (6%) |
| Prior MI | 16 (18%) |
| Hyperlipidemia | 77 (86%) |
| Sleep apnea | 25 (28%) |
| Percutaneous coronary intervention | 11 (12%) |
| Residual neurological deficit | 28 (31%) |
| Medication use | |
| Antiarrhythmic | 2 (2%) |
| Beta blocker | 40 (44%) |
| Calcium channel blocker | 62 (69%) |
| Anticoagulant | 11 (12%) |
| Antihypertensive | 51 (57%) |
| Antiplatelet | 79 (88%) |
| Statin | 82 (91%) |
| Vital signs | |
| BMI, mean (SD) | 32.0 (21.0) |
| Systolic BP, mm Hg, mean (SD) | 131.4 (16.7) |
| Diastolic BP, mm Hg, mean (SD) | 76.0 (8.6) |
| Heart rate, mean (SD) | 73.1 (14.7) |
| Psychosocial variables | |
| Alcohol use | 7 (8%) |
| Cognitive impairment, MoCA <23 for in-person, <17 for phone | 26 (30%) |
| Vision impairment | 48 (54%) |
| Hearing impairment | 26 (29%) |
| Depressive symptoms | |
| None (0–4) | 49 (54%) |
| Mild (5–9) | 27 (30%) |
| Moderate (10–14) | 8 (9%) |
| Moderately severe (15–19) | 3 (3%) |
| Severe (>20) | 3 (3%) |
| Anxiety symptoms | |
| None/minimal (0–4) | 62 (69%) |
| Mild (5–9) | 16 (18%) |
| Moderate (10–14) | 7 (8%) |
| Severe (>15) | 5 (6%) |
| Technology engagement | |
| Device ownership | |
| Tablet | 60 (67%) |
| Smartphone | 74 (83%) |
| Smartwatch | 22 (25%) |
| Basic cellphone (SMS enabled) | 30 (34%) |
| App use frequency (excluding call/text) | |
| Daily | 54 (68%) |
| A few days a week | 12 (15%) |
| At least once a week | 5 (6%) |
| Less than once a week | 2 (3%) |
| Once a month | 3 (4%) |
| Never | 4 (5%) |
Values are n (%) unless otherwise specified.
BMI = body mass index; BP = blood pressure; MI = myocardial infarct; MoCA = Montreal Cognitive Assessment; TIA = transient ischemic attack.
Participant perceptions of the Pulsewatch system
| Usability domain | Percent of participants in agreement (N = 90) |
|---|---|
| Easy to use (smartwatch) | 56 (63.6%) |
| Easy to use (smartphone app) | 46 (52.3%) |
| More connected to healthcare providers | 37 (42.5%) |
| Anxiety or worry from use | 11 (12.5%) |
| Overall enjoyed user experience | 45 (51.1%) |
Factors associated with smartwatch causing anxiety
| Characteristics | Unadjusted OR |
|---|---|
| Age | 1.05 (95% CI: 1.01–1.11) |
| Use of assistive device | 3.34 (95% CI: 1.12–9.96) |
| Baseline depression symptoms | 2.31 (95% CI: 1.01–5.25) |
| Baseline anxiety symptoms | 3.85 (95% CI: 1.56–9.48) |
CI = confidence interval; OR = odds ratio.
Assistive device defined as cane, walker, and wheelchair.
Characteristics of participants who completed an in-depth interview
| Demographics (N = 10 participants) | Result |
|---|---|
| Age, mean (SD) | 62.8 (11.6) |
| Female | 7 (70%) |
| Race | |
| White | 6 (60%) |
| Black | 1 (10%) |
| American Indian/Alaska Native | 1 (10%) |
| More than 1 race | 1 (10%) |
| Other | 1 (10%) |
| Married/living as married | 4 (40%) |
| Education | |
| Less than high school | 1 (10%) |
| High school degree | 5 (50%) |
| College degree | 1 (10%) |
| Postgraduate degree | 3 (30%) |
| Income | |
| Less than $50,000 | 5 (56%) |
| $50,000–$99,999 | 2 (22%) |
| More than $100,000 | 2 (22%) |
| Device ownership | |
| Tablet computer | 8 (80%) |
| Smartphone | 8 (80%) |
| Smartwatch | 2 (20%) |
| Basic cellphone | 4 (40%) |
Values are n (%) unless otherwise specified.
One participant chose not to disclose income (percentages based on N = 9 participants).
Triangulation of quantitative and qualitative usability results
| Outcome of interest | Quantitative results | Qualitative results | Triangulation |
|---|---|---|---|
| Ease of use | 63.7% of participants found watch easy to use | - The devices were simple to use because there was little interaction required—passivity is an important facet of making the devices easier to use for older adults | Convergent / complementary |
| Anxiety from use | 10.2% of participants reported experiencing anxiety or worry from using the system | - Anxiety from use stemmed from not being monitored continuously owing to having to take off the smartwatch for charging or other reasons | Complementary |